Health April 1, 2020Pfizer Collaborates with BioNTech SE to Develop and Distribute Needed Vaccine The agreement covers co-development and co-commercialization aimed at accelerating the development of BioNTech’s potential first-in-class COVID-19 mRNA vaccine program, BNT162, which is expected to enter clinical testing by the end of next month.